(PharmaNewsWire.Com, June 21, 2017 ) Market Data Forecast recently published a report on the North America Stem Cell Market which estimates the market which was worth $5.38 billion in 2016 and expected to be growing at a CAGR of 12.4%, to reach $9.65 billion by 2021 during the forecast period from 2016 to 2021.
Stem cells have tremendous promise to help us understand and treat a range of diseases, injuries and other health-related conditions. Their potential is evident in the use of blood stem cells to treat diseases of the blood, a therapy that has saved the lives of thousands of children with leukemia; and can be seen in the use of stem cells for tissue grafts to treat diseases or injury to the bone, skin and surface of the eye. Important clinical trials involving stem cells are underway for many other conditions and researchers continue to explore new avenues using stem cells in medicine.
There is still a lot to learn about stem cells, however, and their current applications as treatments are sometimes exaggerated by the media and other parties who do not fully understand the science and current limitations, and also by clinics looking to capitalize on the hype by selling treatments to chronically ill or seriously injured patients. The information on this page is intended to help you understand both the potential and the limitations of stem cells at this point in time, and to help you spot some of the misinformation that is widely circulated by clinics offering unproven treatments.
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Some of the key drivers of the North America stem cell market are improved funding from various government and private organizations for research and development for unmet medical needs, growing industry attention on stem cell research, and increasing global awareness about stem cell therapies.
Development of cutting-edge genomic techniques for stem cell analysis, and increasing approvals for clinical trials of stem cell therapy are other factors that are propelling the growth of the market. While on the other hand, ethical issues are involved in the stem cells research and strict regulations to conduct trials on humans are some of the restraining factors. Also factors such as lack of required infrastructure and complications associated with the preservation of stem cell are limiting the growth of the stem cells market.
The market is segmented based on mode of treatment, application, technology and type and is studied for a deep-level understanding of the Stem Cell market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well. By mode of treatment Autologous Allogeneic By application CNS CVS GIT Regenerative Medicine Musculoskeletal Eye & Immune System Development Blood Disorders By technology Cell Acquisition Cell Production Cryopreservation Expansion Sub-Culture By type Adult Stem Cells Human Embryonic Cells Pluripotent Stem Cell Natural Rosette Cells
On the basis of geography, the North America market is analysed under various regions namely the United States and Canada. As of now, North America region dominates the global stem cells market. Europe comes next. The use of stem cells is high in North America since it is a highly developed region. Having access to latest technological developments in health sciences and having people being aware of these helps the market.
Some of the major players in this market are Athersys, StemCells Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.
Scope of the North America Stem Cell Market: Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region To detect major focus areas of industrial growth Segment-level analysis on basis of type, therapeutics, end-user along with market size forecasts and y-o-y estimations are provided Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics PESTLE and Porters Five Forces Analyses that examine the macro& micro environmental factors such as political influence, technological prowess, industry rivalry to name a few. An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clients research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
